Skip to content

Beacon Therapeutics vs Opus Genetics

Beacon Therapeutics logo

Beacon Therapeutics

Transforming Vision, Transforming Lives

95 employees · est. 2023 · London, United Kingdom

VS
Opus Genetics logo

Opus Genetics

Gene therapy company for inherited retinal diseases

42 employees · est. 2021 · Raleigh, United States

Opus Genetics is the older company (2023 vs 2021); Beacon Therapeutics is the larger of the two.

Side-by-Side Comparison

Beacon Therapeutics Opus Genetics
Founded
2023 2021 older
Headquarters
London, United Kingdom Raleigh, United States
Employees
95 larger 42
Industry
Biotechnology, Health Care, Health and Wellness Health Care, Health and Wellness
Funding Stage
Series C Grant
Total Funding
$341.00M $20.70M
Funding Rounds
4 2
Taxonomy
Ophthalmic Gene TherapyRetinal DiseasesX-linked Retinitis PigmentosaAMD (age-related Macular Degeneration)Cone-rod DystrophyGene Therapy Program +8 Gene TherapyInherited Retinal DiseasesClinical-stagePatient-first ApproachOpthamologyStart-up +4
Website
beacontx.com opusgtx.com
Beacon Therapeutics logo

About Beacon Therapeutics

Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases leading to blindness. The company's scientific foundation encompasses a late-stage development candidate...

Opus Genetics logo

About Opus Genetics

Opus Genetics is a pioneering clinical-stage gene therapy company focused on orphan inherited retinal diseases, aiming to put patients at the forefront of their mission. Established in 2004, the company operates in the Health Care industry and is headquartered in the United States. Opus Genetics has...

Also comparing in this category

Comparing more than these two?

Get Beacon Therapeutics, Opus Genetics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Beacon Therapeutics compare?

A PDF of Beacon Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Beacon Therapeutics was founded in 2023, based in London, United Kingdom, with 95 employees. Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases lead. Opus Genetics was founded in 2021, based in Raleigh, United States, with 42 employees. Opus Genetics is a pioneering clinical-stage gene therapy company focused on orphan inherited retinal diseases, aiming to put patients at the forefront of their mission. Established in 2004, the compa.
Beacon Therapeutics has raised $341.00M and Opus Genetics $20.70M. Latest stage: Beacon Therapeutics Series C, Opus Genetics Grant.
Both work in Health Care and Health and Wellness and list inherited retinal diseases among their focus areas.

Compare Beacon Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Beacon Therapeutics on 9 Jun 2026, and Opus Genetics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout